Pacific Biosciences Of California Shares Outstanding 2009-2018 | PACB

Pacific Biosciences Of California shares outstanding history from 2009 to 2018. Shares outstanding can be defined as the number of shares held by shareholders (including insiders) assuming conversion of all convertible debt, securities, warrants and options. This metric excludes the company's treasury shares.
  • Pacific Biosciences Of California shares outstanding for the quarter ending June 30, 2018 were 0.132B, a 35.46% increase year-over-year.
  • Pacific Biosciences Of California 2017 shares outstanding were 0.106B, a 18.55% increase from 2016.
  • Pacific Biosciences Of California 2016 shares outstanding were 0.089B, a 17.9% increase from 2015.
  • Pacific Biosciences Of California 2015 shares outstanding were 0.076B, a 7.29% increase from 2014.
Pacific Biosciences Of California Annual Shares Outstanding
(Millions of Shares)
2017 106
2016 89
2015 76
2014 70
2013 63
2012 56
2011 54
2010 10
2009 1
2008 0
2007 0
Pacific Biosciences Of California Quarterly Shares Outstanding
(Millions of Shares)
Q2 2018 132
Q1 2018 124
Q4 2017 106
Q3 2017 116
Q2 2017 97
Q1 2017 93
Q4 2016 89
Q3 2016 92
Q2 2016 88
Q1 2016 84
Q4 2015 76
Q3 2015 80
Q2 2015 75
Q1 2015 74
Q4 2014 70
Q3 2014 71
Q2 2014 71
Q1 2014 68
Q4 2013 63
Q3 2013 66
Q2 2013 62
Q1 2013 57
Q4 2012 56
Q3 2012 56
Q2 2012 56
Q1 2012 55
Q4 2011 54
Q3 2011 54
Q2 2011 53
Q1 2011 53
Q4 2010 10
Q3 2010 1
Q2 2010 1
Q1 2010 1
Q4 2009 0
Q3 2009 1
Q4 2008 0
Sector Industry Market Cap Revenue
Medical Medical Instruments Manufacturing $0.590B $0.093B
Pacific Biosciences of California, Inc. is engaged in the development, manufacture and commercialization of its single molecule, real-time, or SMRT technology-an integrated platform for genetic analysis. The SMRT technology uses the natural processing power of enzymes, combined with specially designed reagents and detection systems, to record individual biochemical events as they occur. The Company's technology platform comprises of the SMRT cells, Phospholinked nucleotides and the PacBio RS (an instrument that conducts, monitors and analyzes single molecule biochemical reactions in real time). Its product will find its application in both research institutions and commercial companies, including genome centers, government and academic institutions, genomic service providers, pharmaceutical companies and agriculture companies. Pacific Biosciences of California, Inc. is headquartered in Menlo Park, California.
Stock Name Country Market Cap PE Ratio
Thermo Fisher Scientific (TMO) United States $94.718B 22.72
Intuitive Surgical (ISRG) United States $61.755B 58.95
Edwards Lifesciences (EW) United States $30.784B 34.67
Fresenius Medical Care (FMS) Germany $30.559B 21.58
IDEXX Laboratories (IDXX) United States $19.551B 59.42
ABIOMED (ABMD) United States $17.362B 142.24
DexCom (DXCM) United States $11.769B 0.00
Teleflex (TFX) United States $11.435B 27.20
Hologic (HOLX) United States $11.231B 19.11
Varian Medical Systems (VAR) United States $9.888B 24.89
STERIS (STE) United Kingdom $9.320B 25.64
Masimo (MASI) United States $6.246B 41.59
LivaNova (LIVN) United Kingdom $5.709B 34.06
Integra LifeSciences Holdings (IART) United States $5.388B 27.88
Globus Medical (GMED) United States $5.333B 35.48
Penumbra (PEN) United States $4.900B 445.44
Inogen (INGN) United States $4.526B 119.76
Cantel Medical (CMD) United States $3.666B 36.93
Wright Medical Group (WMGI) Netherlands $3.033B 0.00
Halyard Health (AVNS) United States $2.915B 23.99
Integer Holdings (ITGR) United States $2.479B 22.44
Glaukos (GKOS) United States $2.207B 0.00
Opko Health (OPK) United States $2.166B 0.00
Tandem Diabetes Care (TNDM) United States $2.062B 0.00
Nevro (NVRO) United States $1.659B 0.00
Mazor Robotics (MZOR) Israel $1.526B 0.00
AxoGen (AXGN) United States $1.355B 0.00
Luminex (LMNX) United States $1.254B 36.97
CryoLife (CRY) United States $1.234B 108.23
Tactile Systems Technology (TCMD) United States $1.215B 207.06
K2Ms (KTWO) United States $1.195B 0.00
Natus Medical (BABY) United States $1.110B 23.55
Orthofix (OFIX) United States $1.052B 32.03
TransEnterix (TRXC) United States $1.026B 0.00
Accelerate Diagnostics (AXDX) United States $0.920B 0.00
Intersect ENT (XENT) United States $0.901B 0.00
AngioDynamics (ANGO) United States $0.774B 27.07
ViewRay (VRAY) United States $0.709B 0.00
Mesa Laboratories (MLAB) United States $0.686B 42.40
Sientra (SIEN) United States $0.676B 0.00
Oxford Immunotec Global (OXFD) United Kingdom $0.432B 0.00
OrthoPediatrics (KIDS) United States $0.427B 0.00
Neuronetics (STIM) United States $0.425B 0.00
Quotient (QTNT) Switzerland $0.375B 0.00
Veracyte (VCYT) United States $0.375B 0.00
GenMark Diagnostics (GNMK) United States $0.348B 0.00
Accuray (ARAY) United States $0.332B 0.00
Fluidigm (FLDM) United States $0.321B 0.00
Nuvectra (NVTR) United States $0.313B 0.00
RTI Surgical (RTIX) United States $0.300B 59.25
IRadimed (IRMD) United States $0.293B 105.58
Corindus Vascular Robotics (CVRS) United States $0.257B 0.00
CRH Medical (CRHM) Canada $0.251B 31.45
SeaSpine Holdings (SPNE) United States $0.244B 0.00
T2 Biosystems (TTOO) United States $0.221B 0.00
Helius Medical Technologies (HSDT) United States $0.205B 0.00
Pulse Biosciences (PLSE) United States $0.193B 0.00
Invuity (IVTY) United States $0.178B 0.00
RA MEDICAL SYST (RMED) United States $0.138B 0.00
Apollo Endosurgery (APEN) United States $0.138B 0.00
Alphatec Holdings (ATEC) United States $0.136B 0.00
Ekso Bionics Holdings (EKSO) United States $0.130B 0.00
Second Sight Medical Products (EYES) United States $0.114B 0.00
Sensus Healthcare (SRTS) United States $0.111B 0.00
Viveve Medical (VIVE) United States $0.109B 0.00
HTG Molecular Diagnostics (HTGM) United States $0.108B 0.00
Biosig Technologies (BSGM) United States $0.076B 0.00
EDAP TMS (EDAP) France $0.075B 0.00
ConforMIS (CFMS) United States $0.060B 0.00
Electromed (ELMD) United States $0.056B 27.92
Navidea Biopharmaceuticals (NAVB) United States $0.054B 0.00
Restoration Robotics (HAIR) United States $0.053B 0.00
OBALON THERPTCS (OBLN) United States $0.049B 0.00
Neovasc (NVCN) Canada $0.048B 0.00
Xtant Medical Holdings (XTNT) United States $0.045B 0.00
Vermillion (VRML) United States $0.043B 0.00
Titan Medical (TMDI) Canada $0.031B 0.00
Lianluo Smart (LLIT) China $0.030B 0.00
PAVmed (PAVM) United States $0.030B 0.00
ReWalk Robotics (RWLK) Israel $0.029B 0.00
Dynatronics (DYNT) United States $0.025B 0.00
DarioHealth (DRIO) Israel $0.020B 0.00
Presbia (LENS) Ireland $0.020B 0.00
American Shared Hospital Services (AMS) United States $0.019B 15.45
Nanovibronix (NAOV) United States $0.017B 0.00
Microbot Medical (MBOT) United States $0.017B 0.00
Bioanalytical Systems (BASI) United States $0.014B 0.00
Avinger (AVGR) United States $0.013B 0.00
ENDRA Life Sciences (NDRA) United States $0.011B 0.00
Micron Solutions (MICR) United States $0.010B 0.00
Allied Healthcare Products (AHPI) United States $0.008B 0.00
Atossa Genetics (ATOS) United States $0.008B 0.00
Cesca Therapeutics (KOOL) United States $0.008B 0.00
Sunshine Heart Inc (CHFS) United States $0.008B 0.00
InspireMD (NSPR) Israel $0.005B 0.00
Amedica (AMDA) United States $0.004B 0.00
EnteroMedics (RSLS) United States $0.000B 0.00
Check-Cap (CHEK) Israel $0.000B 0.00